Abstract
Recent research implies a role of decreased number and/or function of T-regulatory cells (Tregs) in low-grade inflammation associated with obesity and atherosclerosis. The enhancement of atheroprotective immunity by the expansion of Tregs could serve as a therapeutic strategy in obesity-related immunological disturbances. The aim of our study was an attempt to generate Treg cells in children with risk factors for the development of cardiovascular disease and to compare the results to those obtained in healthy subjects. The study group consisted of 30 children with metabolic syndrome (MS) and 30 controls. Conventional CD4+CD25− cells separated from the peripheral blood were converted into Treg cells with the use of CD3/CD28 antibodies and interleukin (IL)-2/transforming growth factor (TGF)-β stimulation. The expression of critical Treg molecules and cytokines was assessed at mRNA and protein levels. The percentages of Treg cells in the peripheral blood were significantly lower in the children with MS compared to the healthy subjects. After the culture with CD3/CD28 and IL-2/TGF-β we detected a significant increase in the expression of Tregs marker transcription factor FoxP3. The Tregs induced from the children with MS varied from the ones obtained in the controls in the expression of some molecules at mRNA level (e.g. IL-27, LGAL, KLF10 and NRP1) yet not in proliferation studies. For the first time, we have demonstrated the possibility of generating functional Treg cells in children with MS. The results of our study could be used in the design of therapeutic interventions in obesity associated immunologic disturbances.
Similar content being viewed by others
Abbreviations
- FoxP3:
-
Forkhead winged/helix transcription factor 3
- IFN:
-
Interferon
- IL:
-
Interleukin
- iTreg:
-
Induced T-regulatory cell
- MS:
-
Metabolic syndrome
- RT-PCR:
-
Real-time polymerase chain reaction
- TGF:
-
Transforming growth factor
- Tregs:
-
T-regulatory cells
References
Alam MS, Kurtz CC, Rowlett RM et al (2009) CD73 is expressed by human regulatory T helper cells ans suppresses proinflammatory cytokine production and Helicobacter felis-induced gastritis in mice. J Infect Dis 199:494–504
Ammirati E, Cianflone D, Banfi M et al (2010) Circulating CD4 + CD25hiCD127lo regulatory T-cell levels do not reflect the extend or severity of carotid and coronary atherosclerosis. Arterioscler Thromb Vasc Biol 30:1832–1841
Bardel E, Larousserie F, Charlot-Rabiega P et al (2008) Human CD4+CD25+FoxP3+ regulatory T cells do not constitutively express IL-35. J Immunol 181:6898–6905
Barron L, Dooms H, Hoyer KK et al (2010) Cutting edge: mechanisms of IL-2-dependent maintenance of functional regulatory T cells. J Immunol 185:6426–6430
Cipolletta D, Kolodin D, Benoist C et al (2011) Tissular T (regs): a unique population of adipose-tissue resident FoxP3+CD4+ T cells that impacts organismal metabolism. Semin Immunol 23:431–437
Cole TJ, Bellizzi MC, Flegal KM et al (2000) Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 320:1240
Connelly JB, Duaso MJ, Butler G (2007) A systematic review of controlled trials of intervention to prevent childhood obesity and overweight: a realistic synthesis of the evidence. Public Health 121:510–517
Czystowska M, Strauss L, Bergmann C et al (2010) Reciprocal granzyme/perforin-mediated death of human regulatory and responder T cells is regulated by interleukin-2 (IL-2). J Mol Med 88:577–588
Daniels SR, Arnett DK, Eckel RH et al (2005) Overweight in children and adolescents. Pathophysiology, consequences, prevention, and treatment. Circulation 111:1999–2012
de Boer OJ, van der Meer JJ, Teeling P et al (2007) Low numbers of Foxp3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions. PLoS One 2:e779
Deiuliis J, Shah Z, Shah N et al (2011) Visceral adipose inflammation in obesity is associated with critical alterations in T regulatory cell numbers. PLoS One 6:e16376
Dwyer KM, Hanidziar D, Putheti P et al (2010) Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype. Am J Transplant 10:2410–2420
Feuerer M, Herrero L, Cipolletta D et al (2009) Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 15:930–939
Glisic S, Ehlenbach S, Jailwala P et al (2010) Inducible regulatory T cells (iTregs) from recent onset type 1 diabetes subjects show increased in vitro suppression and higher ITCH levels compared with controls. Cell Tissue Res 339:585–595
Gustafson B, Hammarstedt A, Andersson CX et al (2007) Inflamed adipose tissue. A culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 27:2276–2283
Ilan Y, Maron R, Tukpah AM et al (2010) Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice. Proc Natl Acad Sci USA 107:9765–9770
Kleemann R, Zadelaar S, Kooistra T (2008) Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res 79:360–376
Langhans B, Braunschweiger I, Arndt S et al (2010) Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C. Clin Sci 119:97–109
Lin J, Li M, Wang Z et al (2010) The role of CD4+ CD25+ regulatory T cells in macrophage-derived foam-cell formation. J Lipid Res 51:1208–1217
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-ddCT method. Methods 25:402–408
Longhi MS, Meda F, Wang P et al (2008) Expansion and de novo generation of potentiatlly therapeutic regulatory T cells in patients with autoimmune hepatitis. Hepatology 47:581–591
Łuczyński W, Stasiak-Barmuta A, Wawrusiewicz-Kurylonek N et al (2010) Disturbances in some gene expression in T regulatory cells separated from children with metabolic syndrome. Scand J Immunol 71:115–122
Lumeng CN, Saltiel AR (2011) Inflammatory links between obesity and metabolic disease. J Clin Invest 121:2111–2117
Magnussen CH, Koskinen J, Chen W et al (2010) Pediatric metabolic syndrome predicts adulthood metabolic syndrome, subclinical atherosclerosis, and type 2 diabetes mellitus but is no better than body mass index alone: the Bogalusa Heart Study and the Cardiovascular Risk in Young Finns Study. Circulation 122:1604–1611
Mor A, Luboshits G, Planer D et al (2006) Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes. Eur Heart J 27:2530–2537
Mor A, Planer D, Luboshits G et al (2007) Role of naturally occuring CD4+CD25+ regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol 27:893–900
Probst-Kepper M, Geffers R, Kroger A et al (2009) GARP: a key receptor controlling FOXP3 in human regulatory T cells. J Cell Mol Med 13:3343–3357
Shevach EM (2009) Mechanisms of FoxP3+ T regulatory cell-mediated suppression. Immunity 30:636–645
Svec P, Vasarhelyi B, Paszthy B et al (2007) Do regulatory T cells contribute to Th1 skewness in obesity? Exp Clin Endocrinol Diabetes 115:439–443
Tailor AM, Peeters PH, Norat T et al (2010) An update on the prevalence of the metabolic syndrome in children and adolescents. Int J Pediatr Obes 5:202–213
Taleb S, Romain M, Ramkhelawon B et al (2009) Loos of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J Exp Med 206:2067–2077
van Es T, van Puijvelde GH, Foks AC et al (2010) Vaccination against FoxP3(+) regulatory T cells aggravates atherosclerosis. Atherosclerosis 209:74–80
Wigren M, Kolbus D, Dunér P et al (2011) Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine. J Intern Med 269:546–556
Winer S, Chan Y, Paltser G et al (2009) Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 15:921–929
Xie JJ, Wang J, Tang TT et al (2010) The Th17/Treg functional imbalance during atherogenesis in ApoE(−/−) mice. Cytokine 49:185–193
Yi H, Zhen Y, Jiang L et al (2006) The phenotypic characterization of naturally occurring regulatory CD4+ CD25+ T cells. Cell Mol Immunol 3:189–195
Zhao Z, Wu Y, Cheng M et al (2011) Activation of Th17/Th1 and Th1, but not Th17, is associated with the acute cardiac event in patients with acute coronary syndrome. Atherosclerosis 217:518–524
Zimmet P, Alberti KG, Kaufman F et al (2007) The metabolic syndrome in children and adolescents—an IDF consensus report. Pediatr Diabetes 8:299–306
Acknowledgments
The study was supported by the Polish Ministry of Science and Higher Education (grant no. N N407 160937).
Conflict of Interest
We have no conflict of interest to declare.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Łuczyński, W., Wawrusiewicz-Kurylonek, N., Iłendo, E. et al. Generation of Functional T-Regulatory Cells in Children with Metabolic Syndrome. Arch. Immunol. Ther. Exp. 60, 487–495 (2012). https://doi.org/10.1007/s00005-012-0198-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00005-012-0198-6